Found: 46
Select item for more details and to access through your institution.
Primary pulmonary T-cell lymphoproliferative disorders with a limited-stage, low proliferative index, and unusual clinical behavior: two cases of a rare occurrence.
- Published in:
- Virchows Archiv: European Journal of Pathology, 2023, v. 482, n. 5, p. 899, doi. 10.1007/s00428-022-03455-9
- By:
- Publication type:
- Article
Prognostic or predictive value of circulating cytokines and angiogenic factors for initial treatment of multiple myeloma in the GIMEMA MM0305 randomized controlled trial.
- Published in:
- Journal of Hematology & Oncology, 2019, v. 12, n. 1, p. 1, doi. 10.1186/s13045-018-0691-4
- By:
- Publication type:
- Article
Identification of a Maturation Plasma Cell Index through a Highly Sensitive Droplet Digital PCR Assay Gene Expression Signature Validation in Newly Diagnosed Multiple Myeloma Patients.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 20, p. 12450, doi. 10.3390/ijms232012450
- By:
- Publication type:
- Article
Disease-Specific Derangement of Circulating Endocannabinoids and N-Acylethanolamines in Myeloproliferative Neoplasms.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 9, p. 3399, doi. 10.3390/ijms21093399
- By:
- Publication type:
- Article
High levels of CRBN isoform lacking IMiDs binding domain predicts for a worse response to IMiDs-based upfront therapy in newly diagnosed myeloma patients.
- Published in:
- Clinical & Experimental Medicine, 2023, v. 23, n. 8, p. 5227, doi. 10.1007/s10238-023-01205-y
- By:
- Publication type:
- Article
Editorial: Risk factors in multiple myeloma identified before and during treatment: are we ready to personalize treatment?
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1247808
- By:
- Publication type:
- Article
Long term follow-up of humoral and cellular response to mRNA-based vaccines for SARS-CoV-2 in patients with active multiple myeloma.
- Published in:
- Frontiers in Oncology, 2023, p. 01, doi. 10.3389/fonc.2023.1208741
- By:
- Publication type:
- Article
Role of serum‐free light chain assay for defining response and progression in immunoglobulin secretory multiple myeloma.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 12, p. 1607, doi. 10.1002/ajh.26747
- By:
- Publication type:
- Article
The treatment of hairy cell leukemia with a focus on long lasting responses to cladribine: A 30‐year experience.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 10, p. 1204, doi. 10.1002/ajh.26287
- By:
- Publication type:
- Article
Multi-dimensional scaling techniques unveiled gain1q&loss13q co-occurrence in Multiple Myeloma patients with specific genomic, transcriptional and adverse clinical features.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-45000-z
- By:
- Publication type:
- Article
Correlation between eight-gene expression profiling and response to therapy of newly diagnosed multiple myeloma patients treated with thalidomide-dexamethasone incorporated into double autologous transplantation.
- Published in:
- Annals of Hematology, 2013, v. 92, n. 9, p. 1271, doi. 10.1007/s00277-013-1757-6
- By:
- Publication type:
- Article
Long-term results of thalidomide and dexamethasone (thal-dex) as therapy of first relapse in multiple myeloma.
- Published in:
- Annals of Hematology, 2012, v. 91, n. 3, p. 419, doi. 10.1007/s00277-011-1320-2
- By:
- Publication type:
- Article
Circulating Multiple Myeloma Cells (CMMCs) as Prognostic and Predictive Markers in Multiple Myeloma and Smouldering MM Patients.
- Published in:
- Cancers, 2024, v. 16, n. 17, p. 2929, doi. 10.3390/cancers16172929
- By:
- Publication type:
- Article
Synergism Through WEE1 and CHK1 Inhibition in Acute Lymphoblastic Leukemia.
- Published in:
- Cancers, 2019, v. 11, n. 11, p. 1654, doi. 10.3390/cancers11111654
- By:
- Publication type:
- Article
Identification of a novel large EPCAM-MSH2 duplication, concurrently with LOHs in chromosome 20 and X, in a family with Lynch syndrome.
- Published in:
- International Journal of Colorectal Disease, 2019, v. 34, n. 11, p. 1999, doi. 10.1007/s00384-019-03414-y
- By:
- Publication type:
- Article
Targeting the Endothelin-1 Receptors Curtails Tumor Growth and Angiogenesis in Multiple Myeloma.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.600025
- By:
- Publication type:
- Article
Positron emission tomography with computed tomography-based diagnosis of massive extramedullary progression in a patient with high-risk multiple myeloma.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Evaluation of bone disease in multiple myeloma patients carrying the t(4;14) chromosomal translocation.
- Published in:
- European Journal of Haematology, 2008, v. 80, n. 1, p. 31, doi. 10.1111/j.1600-0609.2007.00974.x
- By:
- Publication type:
- Article
P-036: Implementation of IgH/k Next Generation Sequencing for Multiple Myeloma Minimal Residual Disease monitoring: advantages in patients' management during daily clinical practice.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S58, doi. 10.1016/S2152-2650(21)02170-4
- By:
- Publication type:
- Article
OAB-057: Temporal-weight estimation of the copy number alterations of of 1384 Multiple Myeloma patients defines an ancestrality index impacting patients survival.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S35, doi. 10.1016/S2152-2650(21)02129-7
- By:
- Publication type:
- Article
P-053: BoBafit: a Copy Number-clustering tool to refit and recalibrate the diploid region of Multiple Myeloma genomic profiles.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S67, doi. 10.1016/S2152-2650(21)02187-X
- By:
- Publication type:
- Article
OAB-059: Towards a comprehensive multimodal minimal residual disease assessment in multiple myeloma: the role of circulating cell-free DNA to define the extent of disease spreading.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S37, doi. 10.1016/S2152-2650(21)02131-5
- By:
- Publication type:
- Article
OAB-041: Epithelial-mesenchymal-transition regulated by Junctional Adhesion Molecule-A (JAM-A) associates with aggressive extramedullary multiple myeloma disease.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S26, doi. 10.1016/S2152-2650(21)02115-7
- By:
- Publication type:
- Article
OAB-006: A novel algorithm to identify, characterize and define the prognostic impact of complex catastrophic events in Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S4, doi. 10.1016/S2152-2650(21)02080-2
- By:
- Publication type:
- Article
Rare, but complex chromosomal rearrangements, defined "Chromoanagenesis", caused by single-step or stepwise catastrophic genomic events, significantly impact on Multiple Myeloma patients.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e78, doi. 10.1016/j.clml.2019.09.125
- By:
- Publication type:
- Article
VarianThinker: a classification method to confidently approach the mutation heterogeneity in Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e72, doi. 10.1016/j.clml.2019.09.115
- By:
- Publication type:
- Article
A Maturation Index defines Newly Diagnosed Multiple Myeloma Patients with advanced immunophenotypic and Molecular Differentiation profiles associated with poor prognosis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e69, doi. 10.1016/j.clml.2019.09.110
- By:
- Publication type:
- Article
Analysis of the genomic and transcriptomic landscape of chemoresistant multiple myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e58, doi. 10.1016/j.clml.2019.09.091
- By:
- Publication type:
- Article
Age, Disease Status before Blinatumomab, MRD Negativity Obtainment, and Bridge to Transplant Influence Outcome in Patients with B-ALL: A Single Center Experience.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S181, doi. 10.1016/j.clml.2018.07.011
- By:
- Publication type:
- Article
Evolutionary Fitness of Relapsed Multiple Myeloma Patients Who Responded to Upfront Combination Therapy Including New Drugs.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e12, doi. 10.1016/j.clml.2017.03.020
- By:
- Publication type:
- Article
A More Mature Immunophenotypic Make-up of Multiple Myeloma Clone(s) at Diagnosis Correlates With a Higher Genomic Instability.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e11, doi. 10.1016/j.clml.2017.03.019
- By:
- Publication type:
- Article
Blinatumomab is Safe and Effective in Relapsed and MRD Positive B-ALL CD19+ Patients: the Bologna Compassionate Program Experience.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2016, v. 16, p. S14, doi. 10.1016/j.clml.2016.07.022
- By:
- Publication type:
- Article
Circulating cell‐free DNA for target quantification in hematologic malignancies: Validation of a protocol to overcome pre‐analytical biases.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 1, p. 50, doi. 10.1002/hon.3087
- By:
- Publication type:
- Article
Baseline cluster of differentiation 22 fluorescent intensity correlates with patient outcome after Inotuzumab Ozogamicin treatment.
- Published in:
- Hematological Oncology, 2022, v. 40, n. 4, p. 734, doi. 10.1002/hon.3029
- By:
- Publication type:
- Article
Droplet digital polymerase chain reaction for the assessment of disease burden in hairy cell leukemia.
- Published in:
- Hematological Oncology, 2022, v. 40, n. 1, p. 57, doi. 10.1002/hon.2932
- By:
- Publication type:
- Article
Inotuzumab ozogamicin and donor lymphocyte infusion is a safe and promising combination in relapsed acute lymphoblastic leukemia after allogeneic stem cell transplant.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 4, p. 580, doi. 10.1002/hon.2886
- By:
- Publication type:
- Article
Bortezomib-based therapy combined with high cut-off hemodialysis is highly effective in newly diagnosed multiple myeloma patients with severe renal impairment.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 7, p. 647, doi. 10.1002/ajh.24035
- By:
- Publication type:
- Article
Bortezomib- and thalidomide-induced peripheral neuropathy in multiple myeloma: clinical and molecular analyses of a phase 3 study.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 12, p. 1085, doi. 10.1002/ajh.23835
- By:
- Publication type:
- Article
Unraveling the Role of Peroxisome Proliferator-Activated Receptor β/Δ (PPAR β/Δ) in Angiogenesis Associated with Multiple Myeloma.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 7, p. 1011, doi. 10.3390/cells12071011
- By:
- Publication type:
- Article
Phase I/II clinical trial of sequential subcutaneous and intravenous delivery of dendritic cell vaccination for refractory multiple myeloma using patient-specific tumour idiotype protein or idiotype (VDJ)-derived class I-restricted peptides.
- Published in:
- British Journal of Haematology, 2007, v. 139, n. 3, p. 415, doi. 10.1111/j.1365-2141.2007.06832.x
- By:
- Publication type:
- Article
Drug resistance in multiple myeloma: Soldiers and weapons in the bone marrow niche.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 01, doi. 10.3389/fonc.2022.973836
- By:
- Publication type:
- Article
Tracking Response and Resistance in Acute Myeloid Leukemia through Single-Cell DNA Sequencing Helps Uncover New Therapeutic Targets.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 18, p. 10002, doi. 10.3390/ijms251810002
- By:
- Publication type:
- Article
Next-Generation Sequencing for Clinical Management of Multiple Myeloma: Ready for Prime Time?
- Published in:
- Frontiers in Oncology, 2020, p. 1, doi. 10.3389/fonc.2020.00189
- By:
- Publication type:
- Article
Minimal Residual Disease Assessment Within the Bone Marrow of Multiple Myeloma: A Review of Caveats, Clinical Significance and Future Perspectives.
- Published in:
- Frontiers in Oncology, 2019, p. 1, doi. 10.3389/fonc.2019.00699
- By:
- Publication type:
- Article
Selection and transplantation of autologous CD34[sup +] B-lineage negative cells in advanced-phase multiple myeloma patients: a pilot study.
- Published in:
- British Journal of Haematology, 1999, v. 107, n. 2, p. 419, doi. 10.1046/j.1365-2141.1999.01691.x
- By:
- Publication type:
- Article
Generation and functional characterization of human dendritic cells derived from CD34+ cells mobilized into peripheral blood: comparison with bone marrow CD34+ cells.
- Published in:
- British Journal of Haematology, 1998, v. 101, n. 4, p. 756, doi. 10.1046/j.1365-2141.1998.00771.x
- By:
- Publication type:
- Article